Side effects of PT-141 include nausea, flushing, headache, and injection site reactions. Learn which cardiovascular risks matter and who should avoid it.
PT-141 (bremelanotide) is a melanocortin receptor agonist that the FDA approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. Its most commonly reported side effects are nausea, flushing, headache, and injection site reactions, and it can also raise blood pressure and darken the skin with repeated use. Most reactions are mild to moderate and fade within hours, but the cardiovascular effects are serious enough that PT-141 is not appropriate for people with uncontrolled hypertension or known heart disease.
What Is PT-141 and How Is It Used?
PT-141 is a synthetic cyclic peptide derived from alpha-melanocyte-stimulating hormone. It works by activating melanocortin receptors in the central nervous system rather than by increasing genital blood flow, which is how PDE5 inhibitors such as sildenafil work.
The approved product is a 1.75 mg subcutaneous autoinjector used as needed at least 45 minutes before sexual activity. The label limits dosing to once in 24 hours and no more than eight doses per month.
PT-141 sold as a research peptide by online vendors is not FDA-approved for human use. Those products are not reviewed for purity, dose accuracy, or sterility, so contamination and dosing errors are genuine risks.
Most Common Side Effects of PT-141
Two phase 3 trials in premenopausal women with HSDD, known as the RECONNECT studies, provide most of the safety data. The question of what are the side effects of pt 141 has a fairly consistent answer across those trials.
| Side effect | How common | What it typically feels like |
|---|---|---|
| Nausea | About 40% | Most frequent effect; usually mild to moderate, peaks within an hour |
| Flushing | About 20% | Warmth or redness in the face, neck, and chest; short-lived |
| Injection site reactions | About 13% | Pain, bruising, itching, or redness at the injection spot |
| Headache | About 11% | Usually mild and resolves without treatment |
| Vomiting | About 5% | More likely at higher doses |
| Fatigue, dizziness, hot flashes, diarrhea | Less common | Reported but infrequent in trials |
Most pt 141 peptide side effects reported in trials were mild to moderate, and only a small share of participants stopped treatment because of them.
Does PT-141 Raise Blood Pressure?
Yes. PT-141 causes a short-lived rise in blood pressure, typically a few points of both systolic and diastolic pressure that peaks within a few hours of dosing. This effect is the main reason the drug is contraindicated in people with uncontrolled hypertension or known cardiovascular disease.
The label advises assessing cardiovascular risk before starting treatment and checking blood pressure during use. A history of heart attack, stroke, or arrhythmia generally makes PT-141 a poor choice.
PT-141 also slows gastric emptying, which can change how quickly oral medications are absorbed. That matters for drugs with a narrow therapeutic window.
Skin Darkening and Hyperpigmentation
Repeated use of PT-141 can cause darkening of the skin, including the face and gums. This is a known class effect of melanocortin agonists, and the discoloration may not fully reverse after the drug is stopped.
Reported cases range from mild tanning to focal patches. Because the change develops gradually over weeks or months, many users do not notice it until it becomes obvious to other people.
PT-141 Nasal Spray and Compounded Versions
An intranasal formulation was studied before the injectable was approved, but development was halted in 2007. Early research on pt-141 peptide nasal spray side effects showed similar blood pressure elevation, which is one reason that version was set aside.
Compounded or research-grade versions sold online carry a different set of risks:
- Inaccurate peptide content or dosing
- Bacterial contamination when sterility is not maintained
- Unknown storage conditions that degrade the peptide
- No formal system for reporting adverse events
Who Should Not Use PT-141
- People with uncontrolled high blood pressure
- People with known cardiovascular disease
- Anyone who is pregnant or breastfeeding, since there are no safety data
- People looking for an FDA-approved option outside the premenopausal HSDD indication
Vyleesi was studied only in premenopausal women, so the pt-141 for women side effects profile is based almost entirely on that group. Men who use PT-141 for erectile dysfunction are using it off-label, and earlier trials in men were stopped because of increases in blood pressure.
Anyone comparing injectables should also note that the side effects of lipo c injections have nothing to do with melanocortin biology and carry an entirely different risk profile.
How Long Do Side Effects Last?
Nausea and flushing usually begin within 30 to 60 minutes of injection and resolve within a few hours. Injection site reactions may last a day or two. Skin darkening and blood pressure changes are cumulative concerns rather than one-time reactions.
Practical steps that may lower risk include rotating injection sites, using the lowest effective dose, staying within the once-per-24-hours and eight-doses-per-month limits, and tracking blood pressure at home.
When to Contact a Healthcare Professional
Seek medical attention for severe or persistent vomiting, a blood pressure reading well above your normal range combined with chest pain or a severe headache, sudden skin color changes, or an injection site reaction that spreads or appears infected.
This article is informational and is not a substitute for medical advice. Talk with a healthcare professional about your own cardiovascular risk before starting PT-141.
Frequently Asked Questions
How long do PT-141 side effects last?
Nausea and flushing typically start within 30 to 60 minutes of the injection and ease within a few hours. Injection site reactions can linger for a day or two. Skin darkening and blood pressure changes are different because they build up with repeated dosing rather than appearing as a single short reaction.
Is PT-141 FDA-approved for men?
No. Bremelanotide is FDA-approved only as Vyleesi, a subcutaneous injection for hypoactive sexual desire disorder in premenopausal women. Men who use PT-141 for erectile dysfunction are using it off-label, and early clinical trials in men were discontinued because of blood pressure elevations.
Does PT-141 cause permanent skin darkening?
PT-141 can cause hyperpigmentation of the skin, including the face and gums, and in some reported cases the darkening does not fully fade after the drug is stopped. The effect usually develops gradually with repeated use, so it may go unnoticed for weeks or months.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.